Back
Pacific Biosciences of California Vs. Co-Diagnostics Industry Stock Comparison
Sell
41
PACB
Pacific Biosciences of California
Last Price:
1.87
Seasonality Move:
-2.25%
Buy
64
CODX
Co-Diagnostics
Last Price:
1.26
Seasonality Move:
32.58%
Sell
41
Pacific Biosciences of California (PACB)
is a Sell
Is Pacific Biosciences of California a Buy, Sell or Hold?
- The current Pacific Biosciences of California [PACB] share price is $1.76. The Score for PACB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- PACB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Co-Diagnostics (CODX)
is a Buy
Is Co-Diagnostics a Buy, Sell or Hold?
- The current Co-Diagnostics [CODX] share price is $1.20. The Score for CODX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- CODX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PACB Stock Price Chart
What is Pacific Biosciences of California's stock price today?
-
The Pacific Biosciences of California share price today is $1.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing slight selling pressure.
CODX Stock Price Chart
What is Co-Diagnostics's stock price today?
-
The Co-Diagnostics share price today is $1.20
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CODX is experiencing buying pressure, which is a positive indicator for future bullish movement.
PACB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.58 | Sell |
| Relative Strength Index (14 RSI): | 32.68 | Sell |
| Chaikin Money Flow: | -2040628 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.46 - 3.36) | Sell |
| Bollinger Bands (100): | (2.99 - 8.15) | Sell |
CODX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 56.33 | Buy |
| Chaikin Money Flow: | 32646 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.13 - 1.21) | Buy |
| Bollinger Bands (100): | (1.11 - 1.29) | Sell |
PACB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.55 | Buy |
| 20-day SMA: | 2.14 | Sell |
| 50-day SMA: | 3.4 | Sell |
| 200-day SMA: | 7.51 | Sell |
| 8-day EMA: | 1.67 | Buy |
| 20-day EMA: | 2.11 | Sell |
| 50-day EMA: | 3.34 | Sell |
| 200-day EMA: | 6.66 | Sell |
CODX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Buy |
| 20-day SMA: | 1.18 | Buy |
| 50-day SMA: | 1.15 | Buy |
| 200-day SMA: | 1.21 | Sell |
| 8-day EMA: | 1.17 | Buy |
| 20-day EMA: | 1.16 | Buy |
| 50-day EMA: | 1.17 | Buy |
| 200-day EMA: | 1.35 | Sell |
Pacific Biosciences of California Earnings Growth & PACB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.01 per share, an increase this year of $0.16 per share, and an increase next year of $0.19 per share.
Co-Diagnostics Earnings Growth & CODX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.00 per share.
Pacific Biosciences of California Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Co-Diagnostics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||